Torsade de pointes: Difference between revisions
Jump to navigation
Jump to search
Line 32: | Line 32: | ||
#* because of bradycardia and a prolonged QT syndrome | #* because of bradycardia and a prolonged QT syndrome | ||
# Organophosphate poisoning <ref>Chou's Electrocardiography in Clinical Practice Third Edition, pp. 398-409.</ref> <ref>Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:194 ISBN 1591032016</ref> | # Organophosphate poisoning <ref>Chou's Electrocardiography in Clinical Practice Third Edition, pp. 398-409.</ref> <ref>Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:194 ISBN 1591032016</ref> | ||
==Additional Information== | ==Additional Information== |
Revision as of 01:57, 15 October 2012
Torsade de pointes | |
DiseasesDB | 29252 |
---|---|
MeSH | D016171 |
Torsades de pointes Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Torsade de pointes On the Web |
American Roentgen Ray Society Images of Torsade de pointes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Clinical Correlation
- Drugs: quinidine, PCA, norpace, amiodarone, phenothiazines, Tricyclic antidepressants, pentamidine.
- with quinidine majority of the cases occur within one week of initiation, and with therapeutic levels
- Electrolyte imbalances: Hypokalemia, hypomagnesemia, hypocalcemia
- CAD
- MVP
- Variant angina
- Myocarditis
- Subarachnoid hemorrhage
- Congenital QT prolongation
- Liquid protein diets
- Hypothyroidism
- because of bradycardia and a prolonged QT syndrome
- Organophosphate poisoning [1] [2]